Five biopsy specimens from the proximal part of the tumor reliably determine HER2 protein expression status in gastric cancer

BACKGROUND: National guidelines recommend trastuzumab for treatment of patients with metastatic HER2-positive gastric cancer (GC). There is currently no guideline indicating the number of biopsy specimens and the location from which they should be obtained to reliably determine the human epidermal g...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Gastric Cancer
Autors principals: Tominaga, Naoyuki, Gotoda, Takuji, Hara, Megumi, Hale, Matthew D., Tsuchiya, Takayoshi, Matsubayashi, Jun, Kono, Shin, Kusano, Chika, Itoi, Takao, Fujimoto, Kazuma, Moriyasu, Fuminori, Grabsch, Heike I.
Format: Artigo
Idioma:Inglês
Publicat: Springer Japan 2015
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4824804/
https://ncbi.nlm.nih.gov/pubmed/25987463
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10120-015-0502-3
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars